Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes

ObjectiveThe objective of this study is to investigate whether chronic inflammatory demyelinating polyneuropathy (CIDP) and its subtypes differ in their type 1 T-helper (TH1) cell response against nodal/paranodal neurofascin (NF186, NF155) as well as myelin protein zero (P0 180–199) and myelin basic...

Full description

Bibliographic Details
Main Authors:	Jan-Markus Diederich, Maximilian Staudt, Christian Meisel, Katrin Hahn, Edgar Meinl, Andreas Meisel, Juliane Klehmet
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-03-01
Series:	Frontiers in Neurology
Subjects:	chronic inflammatory demyelinating polyneuropathy neurofascin myelin basic protein myelin protein zero T cell response chronic inflammatory demyelinating polyneuropathy subtypes
Online Access:	http://journal.frontiersin.org/article/10.3389/fneur.2018.00171/full

Similar Items

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
by: Jun-ichi Kira, et al.
Published: (2021-06-01)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies
by: Laurent Bailly, et al.
Published: (2018-12-01)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
by: Syed Bukhari, et al.
Published: (2020-11-01)

Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
by: A. S. Rizvanova, et al.
Published: (2020-03-01)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)

Depression with chronic inflammatory demyelinating polyneuropathy
by: Arun Marwale, et al.
Published: (2018-01-01)

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
by: Frauke Stascheit, et al.
Published: (2021-09-01)

Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—<i>A Systematic Review</i>
by: Elena-Sonia Moise, et al.
Published: (2022-07-01)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a Patient with Diabetes: a primary care perspective
by: Jordan Dever, et al.
Published: (2020-10-01)

A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy
by: Karissa L. Gable, et al.
Published: (2022-08-01)

Childhood subacute inflammatory demyelinating polyneuropathy
by: Chia-Yu Hsu, et al.
Published: (2011-11-01)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
by: Rajabally YA, et al.
Published: (2020-09-01)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
by: Cheng-Yin Tan, et al.
Published: (2023-04-01)

Acute‐onset chronic inflammatory demyelinating polyneuropathy with cranial nerves and respiratory tract involvement: A case report
by: Malek Mansour, et al.
Published: (2020-11-01)

Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
by: Ivo Bozovic, et al.
Published: (2023-08-01)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
by: Tomohiro Hayashi, et al.
Published: (2021-05-01)

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective
by: Dario Cocito, et al.
Published: (2023-11-01)

Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies, and questions
by: Jay Desai, et al.
Published: (2015-01-01)

Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy
by: Babita Gupta, et al.
Published: (2011-01-01)

Colorectal carcinoma and chronic inflammatory demyelinating polyneuropathy: is there a possible paraneoplastic association?
by: Adnan Malik, et al.
Published: (2023-03-01)

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology
by: Cristina Gatcan, et al.
Published: (2023-12-01)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
by: Farzad Fatehi, et al.
Published: (2013-01-01)

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US
by: Guptill JT, et al.
Published: (2019-04-01)

Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy
by: Monica Alcantara, et al.
Published: (2022-04-01)

Missed diagnosis of chronic inflammatory demyelinating polyneuropathy in a patient with cervical myelopathy due to ossification of posterior longitudinal ligament
by: Min Cheol Chang
Published: (2018-10-01)

Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01)

PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01)

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
by: Edyta Dziadkowiak, et al.
Published: (2021-12-01)

Anesthetic management of a patient with chronic inflammatory demyelinating polyneuropathy by combination of total intravenous and regional anesthesia
by: Daiki Takekawa, et al.
Published: (2019-03-01)

Chronic inflammatory demyelinating polyneuropathy with hypoglossal nerve involvement and inverted Beevor’s sign: case report
by: Huajian Zhao, et al.
Published: (2021-06-01)

Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot–Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection
by: Da Li, et al.
Published: (2024-04-01)

Chronic Inflammatory Demyelinating Polyradiculoneuropaty: Post-Pandemic Review
by: Hilal Taştekin Toz
Published: (2023-09-01)

The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
by: Chafké Belmokhtar, et al.
Published: (2019-03-01)

Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report
by: Yan Jin, et al.
Published: (2022-11-01)

The Misdiagnosis of CIDP: A Review
by: Jeffrey A. Allen
Published: (2020-03-01)

Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy
by: Kamel Mahmoud Ali Hewedi, et al.
Published: (2020-06-01)

Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins
by: Yang M, et al.
Published: (2022-06-01)

Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study
by: Yongsheng Zheng, et al.
Published: (2024-01-01)